Franklin Street Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Franklin Street Advisors's DGX Position: Q2 2026 in Review
Franklin Street Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,431 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #148.
Franklin Street Advisors first reported a position in DGX in Q4 2018 and has held it in 20 quarters since. The position peaked at $350K in Q3 2025. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Franklin Street Advisors held 1,431 shares of Quest Diagnostics worth $303K as of Q2 2026.
- Franklin Street Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.02% of Franklin Street Advisors's portfolio in Q2 2026, its #148 holding.
- Franklin Street Advisors first reported a position in Quest Diagnostics in Q4 2018 and has held it in 20 quarters since.
- Franklin Street Advisors's Quest Diagnostics position peaked at $350K in Q3 2025.
- 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.